 Robert Enzenauer
Concepts (543)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amblyopia | 7 | 2023 | 8 | 1.930 |
Why?
| | Ophthalmologic Surgical Procedures | 8 | 2019 | 56 | 1.630 |
Why?
| | Vision Screening | 4 | 2023 | 9 | 1.610 |
Why?
| | Retinopathy of Prematurity | 9 | 2021 | 138 | 1.490 |
Why?
| | Strabismus | 9 | 2017 | 28 | 1.320 |
Why?
| | Refractive Errors | 4 | 2023 | 18 | 1.270 |
Why?
| | Oculomotor Muscles | 11 | 2017 | 38 | 1.230 |
Why?
| | Cornea | 9 | 2021 | 114 | 1.210 |
Why?
| | Ophthalmology | 6 | 2021 | 81 | 0.900 |
Why?
| | Eye Injuries, Penetrating | 3 | 2013 | 16 | 0.820 |
Why?
| | Military Medicine | 4 | 2016 | 61 | 0.790 |
Why?
| | Military Personnel | 8 | 2018 | 517 | 0.760 |
Why?
| | Eye Injuries | 8 | 2016 | 45 | 0.720 |
Why?
| | Eye Foreign Bodies | 3 | 2014 | 23 | 0.710 |
Why?
| | Photography | 3 | 2010 | 98 | 0.680 |
Why?
| | Endophthalmitis | 5 | 2002 | 28 | 0.670 |
Why?
| | Chemical Warfare Agents | 6 | 2021 | 109 | 0.650 |
Why?
| | Exotropia | 4 | 2006 | 5 | 0.630 |
Why?
| | Patient Simulation | 1 | 2019 | 31 | 0.620 |
Why?
| | Lighting | 2 | 2016 | 26 | 0.610 |
Why?
| | Tensile Strength | 2 | 2017 | 97 | 0.600 |
Why?
| | Amnion | 1 | 2017 | 25 | 0.580 |
Why?
| | Equipment Design | 1 | 2019 | 518 | 0.550 |
Why?
| | Down Syndrome | 1 | 2023 | 470 | 0.550 |
Why?
| | Eye Infections, Bacterial | 3 | 2002 | 26 | 0.550 |
Why?
| | Teaching | 1 | 2019 | 209 | 0.540 |
Why?
| | Esotropia | 4 | 2006 | 7 | 0.530 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2016 | 38 | 0.520 |
Why?
| | Color Vision | 1 | 2016 | 3 | 0.510 |
Why?
| | Wound Healing | 3 | 2017 | 310 | 0.510 |
Why?
| | Color | 1 | 2016 | 74 | 0.500 |
Why?
| | Neonatal Screening | 5 | 2021 | 163 | 0.470 |
Why?
| | Delivery of Health Care | 2 | 2013 | 892 | 0.460 |
Why?
| | Boxing | 5 | 1994 | 6 | 0.440 |
Why?
| | Ophthalmic Solutions | 5 | 2017 | 73 | 0.440 |
Why?
| | Tissue Adhesions | 2 | 2017 | 29 | 0.430 |
Why?
| | Humans | 117 | 2023 | 128524 | 0.430 |
Why?
| | Visual Acuity | 11 | 2013 | 320 | 0.420 |
Why?
| | Vitrectomy | 4 | 2007 | 62 | 0.420 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 245 | 0.420 |
Why?
| | Retinoscopes | 1 | 2011 | 1 | 0.360 |
Why?
| | Insurance, Liability | 1 | 2010 | 6 | 0.350 |
Why?
| | Rabbits | 8 | 2021 | 761 | 0.350 |
Why?
| | Dacryocystitis | 1 | 2010 | 3 | 0.350 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.350 |
Why?
| | Infant, Newborn | 27 | 2021 | 5687 | 0.340 |
Why?
| | Nonprescription Drugs | 2 | 2003 | 69 | 0.340 |
Why?
| | Pupil Disorders | 1 | 2010 | 5 | 0.340 |
Why?
| | Mustard Gas | 3 | 2021 | 104 | 0.330 |
Why?
| | Corneal Injuries | 2 | 2021 | 41 | 0.330 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 17 | 0.330 |
Why?
| | Reimbursement Mechanisms | 1 | 2010 | 84 | 0.330 |
Why?
| | Warfare | 3 | 2018 | 63 | 0.330 |
Why?
| | Sensitivity and Specificity | 6 | 2023 | 1820 | 0.320 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 5346 | 0.310 |
Why?
| | Decompression, Surgical | 3 | 2019 | 98 | 0.310 |
Why?
| | Mechlorethamine | 3 | 2019 | 56 | 0.300 |
Why?
| | Corneal Neovascularization | 3 | 2017 | 12 | 0.290 |
Why?
| | Vitreous Detachment | 1 | 2007 | 7 | 0.290 |
Why?
| | Developmental Disabilities | 1 | 2011 | 254 | 0.290 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2007 | 30 | 0.280 |
Why?
| | Optic Disk | 1 | 2007 | 40 | 0.280 |
Why?
| | Vitreous Body | 1 | 2007 | 102 | 0.270 |
Why?
| | Circumcision, Male | 5 | 1987 | 14 | 0.270 |
Why?
| | Arsenicals | 2 | 2017 | 28 | 0.270 |
Why?
| | Birth Weight | 5 | 2017 | 498 | 0.270 |
Why?
| | Weight Gain | 3 | 2016 | 505 | 0.260 |
Why?
| | Infant | 25 | 2017 | 8913 | 0.260 |
Why?
| | Photorefractive Keratectomy | 1 | 2006 | 19 | 0.260 |
Why?
| | Orbit | 3 | 2013 | 56 | 0.260 |
Why?
| | Horner Syndrome | 1 | 2006 | 2 | 0.260 |
Why?
| | Choristoma | 1 | 2006 | 21 | 0.250 |
Why?
| | Indans | 1 | 2005 | 10 | 0.250 |
Why?
| | Corneal Transplantation | 2 | 2005 | 13 | 0.250 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2005 | 16 | 0.250 |
Why?
| | Nootropic Agents | 1 | 2005 | 28 | 0.240 |
Why?
| | Neck | 1 | 2006 | 92 | 0.240 |
Why?
| | Cataract Extraction | 3 | 2002 | 96 | 0.240 |
Why?
| | Hypergammaglobulinemia | 2 | 1999 | 9 | 0.240 |
Why?
| | Retinal Hemorrhage | 5 | 2013 | 18 | 0.240 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 1936 | 0.240 |
Why?
| | Keratomileusis, Laser In Situ | 1 | 2005 | 21 | 0.240 |
Why?
| | Thymus Gland | 1 | 2006 | 309 | 0.230 |
Why?
| | Ocular Motility Disorders | 2 | 2003 | 26 | 0.230 |
Why?
| | Mathematical Computing | 1 | 2004 | 11 | 0.230 |
Why?
| | Vitamin A Deficiency | 1 | 2004 | 27 | 0.230 |
Why?
| | Multiple Sclerosis | 1 | 2010 | 434 | 0.230 |
Why?
| | Contact Lenses, Hydrophilic | 2 | 1997 | 5 | 0.230 |
Why?
| | Child | 17 | 2023 | 20721 | 0.220 |
Why?
| | Orbital Fractures | 1 | 2004 | 9 | 0.220 |
Why?
| | Retinal Detachment | 2 | 2002 | 56 | 0.220 |
Why?
| | Vision, Ocular | 2 | 2016 | 33 | 0.220 |
Why?
| | Piperidines | 1 | 2005 | 190 | 0.220 |
Why?
| | Corneal Diseases | 2 | 2015 | 34 | 0.220 |
Why?
| | Diplopia | 1 | 2003 | 17 | 0.210 |
Why?
| | Suture Techniques | 3 | 1999 | 121 | 0.210 |
Why?
| | Risk Factors | 9 | 2023 | 9727 | 0.200 |
Why?
| | Dry Eye Syndromes | 1 | 2003 | 53 | 0.200 |
Why?
| | Drug Costs | 1 | 2003 | 103 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3023 | 0.200 |
Why?
| | Male | 54 | 2020 | 62883 | 0.200 |
Why?
| | Eyelids | 3 | 2013 | 33 | 0.200 |
Why?
| | Intraocular Pressure | 6 | 2013 | 296 | 0.200 |
Why?
| | Female | 47 | 2017 | 68127 | 0.200 |
Why?
| | Astigmatism | 2 | 2011 | 10 | 0.200 |
Why?
| | Blepharoptosis | 1 | 2002 | 7 | 0.190 |
Why?
| | Disabled Children | 1 | 2003 | 68 | 0.190 |
Why?
| | Granuloma, Foreign-Body | 1 | 2002 | 10 | 0.190 |
Why?
| | Physical Examination | 1 | 2023 | 235 | 0.190 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2002 | 10 | 0.190 |
Why?
| | Sclerostomy | 1 | 2001 | 4 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2003 | 249 | 0.190 |
Why?
| | Abducens Nerve Diseases | 1 | 2002 | 12 | 0.190 |
Why?
| | Myopia | 2 | 2011 | 47 | 0.190 |
Why?
| | Hospitalization | 3 | 2010 | 2071 | 0.190 |
Why?
| | Child, Preschool | 17 | 2020 | 10373 | 0.190 |
Why?
| | Epithelium, Corneal | 3 | 2017 | 36 | 0.190 |
Why?
| | Tissue Donors | 2 | 2005 | 386 | 0.180 |
Why?
| | Echolalia | 1 | 2001 | 1 | 0.180 |
Why?
| | Vigabatrin | 1 | 2021 | 18 | 0.180 |
Why?
| | Aniridia | 1 | 2020 | 4 | 0.180 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 19 | 0.180 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2001 | 15 | 0.180 |
Why?
| | Trabeculectomy | 1 | 2001 | 71 | 0.180 |
Why?
| | Codon, Nonsense | 1 | 2020 | 39 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 132 | 0.180 |
Why?
| | Retinal Diseases | 5 | 1994 | 86 | 0.180 |
Why?
| | Immunoglobulin G | 2 | 1999 | 837 | 0.180 |
Why?
| | Arthritis | 3 | 2017 | 114 | 0.170 |
Why?
| | Eye Proteins | 1 | 2020 | 87 | 0.170 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1197 | 0.170 |
Why?
| | Leadership | 1 | 2004 | 356 | 0.170 |
Why?
| | Cyclooxygenase 2 | 5 | 2021 | 172 | 0.170 |
Why?
| | Glaucoma, Open-Angle | 1 | 2001 | 101 | 0.170 |
Why?
| | Prospective Studies | 7 | 2019 | 7043 | 0.170 |
Why?
| | Drug Residues | 1 | 1999 | 5 | 0.170 |
Why?
| | Scleral Buckling | 1 | 1999 | 18 | 0.170 |
Why?
| | Postoperative Complications | 3 | 2017 | 2479 | 0.170 |
Why?
| | Disease Models, Animal | 3 | 2019 | 3943 | 0.160 |
Why?
| | Corneal Stroma | 2 | 2017 | 15 | 0.160 |
Why?
| | Wilms Tumor | 1 | 2020 | 77 | 0.160 |
Why?
| | Sclera | 1 | 1999 | 36 | 0.160 |
Why?
| | Organ Preservation Solutions | 1 | 1999 | 43 | 0.160 |
Why?
| | Lacrimal Apparatus | 1 | 2019 | 7 | 0.160 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 1999 | 6 | 0.160 |
Why?
| | Paraproteinemias | 1 | 1999 | 4 | 0.160 |
Why?
| | Functional Laterality | 2 | 2010 | 218 | 0.160 |
Why?
| | Anticonvulsants | 1 | 2021 | 197 | 0.160 |
Why?
| | Retinal Vein Occlusion | 1 | 1999 | 13 | 0.160 |
Why?
| | Organ Preservation | 1 | 1999 | 92 | 0.160 |
Why?
| | United States | 13 | 2021 | 13876 | 0.150 |
Why?
| | Face | 1 | 2020 | 167 | 0.150 |
Why?
| | Contrast Sensitivity | 1 | 2018 | 13 | 0.150 |
Why?
| | Vision Tests | 1 | 2018 | 16 | 0.150 |
Why?
| | Pneumococcal Infections | 1 | 1999 | 110 | 0.150 |
Why?
| | Color Perception | 1 | 2018 | 22 | 0.150 |
Why?
| | Adolescent | 16 | 2016 | 20213 | 0.150 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2021 | 113 | 0.150 |
Why?
| | Staphylococcal Infections | 3 | 2011 | 380 | 0.150 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 76 | 0.150 |
Why?
| | Gestational Age | 6 | 2017 | 862 | 0.150 |
Why?
| | Retrobulbar Hemorrhage | 2 | 2009 | 3 | 0.150 |
Why?
| | Naphazoline | 1 | 1997 | 1 | 0.150 |
Why?
| | Pheniramine | 1 | 1997 | 1 | 0.150 |
Why?
| | Nasal Decongestants | 1 | 1997 | 8 | 0.150 |
Why?
| | Conjunctivitis, Allergic | 1 | 1997 | 4 | 0.150 |
Why?
| | Atropine | 1 | 2017 | 24 | 0.150 |
Why?
| | Histamine H1 Antagonists | 1 | 1997 | 29 | 0.150 |
Why?
| | Mydriasis | 1 | 1997 | 9 | 0.140 |
Why?
| | Nerve Agents | 1 | 2017 | 6 | 0.140 |
Why?
| | Athletic Injuries | 3 | 1989 | 517 | 0.140 |
Why?
| | Adult | 21 | 2018 | 35315 | 0.140 |
Why?
| | Conjunctiva | 1 | 2017 | 51 | 0.140 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.140 |
Why?
| | Retrospective Studies | 15 | 2021 | 14460 | 0.140 |
Why?
| | Meningitis | 3 | 1983 | 80 | 0.140 |
Why?
| | Antimetabolites | 1 | 1997 | 22 | 0.140 |
Why?
| | Synovitis | 1 | 2017 | 25 | 0.140 |
Why?
| | Drug Therapy, Combination | 5 | 2012 | 1009 | 0.140 |
Why?
| | Quality Indicators, Health Care | 1 | 1999 | 296 | 0.140 |
Why?
| | Educational Measurement | 1 | 2019 | 261 | 0.130 |
Why?
| | Cicatrix | 1 | 1997 | 58 | 0.130 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 349 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 534 | 0.130 |
Why?
| | Orbital Neoplasms | 2 | 1993 | 20 | 0.130 |
Why?
| | Health Personnel | 2 | 2000 | 646 | 0.130 |
Why?
| | Swine | 1 | 2019 | 743 | 0.130 |
Why?
| | False Positive Reactions | 2 | 2011 | 113 | 0.130 |
Why?
| | Infant, Newborn, Diseases | 3 | 1982 | 108 | 0.130 |
Why?
| | Treatment Outcome | 10 | 2011 | 10163 | 0.130 |
Why?
| | Fluorouracil | 1 | 1997 | 197 | 0.130 |
Why?
| | Uveitis | 1 | 2017 | 127 | 0.130 |
Why?
| | Antidotes | 1 | 2017 | 136 | 0.130 |
Why?
| | Visual Fields | 3 | 2007 | 88 | 0.120 |
Why?
| | Afghanistan | 2 | 2007 | 71 | 0.120 |
Why?
| | Convergence, Ocular | 1 | 1995 | 6 | 0.120 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.120 |
Why?
| | Public Health | 1 | 2000 | 486 | 0.120 |
Why?
| | Eye Burns | 1 | 2015 | 11 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 522 | 0.120 |
Why?
| | Algorithms | 3 | 2017 | 1616 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 6 | 2010 | 3366 | 0.120 |
Why?
| | Animals | 9 | 2021 | 34501 | 0.120 |
Why?
| | Ethanol | 1 | 1999 | 585 | 0.120 |
Why?
| | Burns, Chemical | 1 | 2015 | 28 | 0.120 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 307 | 0.120 |
Why?
| | Quality of Health Care | 1 | 1999 | 607 | 0.120 |
Why?
| | Keratitis | 2 | 2017 | 11 | 0.120 |
Why?
| | Interleukin-8 | 3 | 2021 | 258 | 0.110 |
Why?
| | Slit Lamp | 1 | 2014 | 3 | 0.110 |
Why?
| | Hyphema | 1 | 2013 | 4 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2019 | 501 | 0.110 |
Why?
| | Keratotomy, Radial | 1 | 1993 | 9 | 0.110 |
Why?
| | Lymphangioma | 1 | 1993 | 7 | 0.110 |
Why?
| | DNA Damage | 1 | 2016 | 364 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1001 | 0.110 |
Why?
| | Blindness | 2 | 2009 | 37 | 0.110 |
Why?
| | Health Care Surveys | 2 | 2010 | 557 | 0.100 |
Why?
| | Scleral Diseases | 1 | 1992 | 1 | 0.100 |
Why?
| | Staphylococcus | 2 | 2011 | 74 | 0.100 |
Why?
| | Abducens Nerve | 1 | 1992 | 3 | 0.100 |
Why?
| | Eye Infections, Fungal | 1 | 1992 | 6 | 0.100 |
Why?
| | Dura Mater | 1 | 1992 | 32 | 0.100 |
Why?
| | Skull Neoplasms | 1 | 1992 | 23 | 0.100 |
Why?
| | Anesthetics, Dissociative | 1 | 2012 | 28 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 3881 | 0.100 |
Why?
| | Cranial Nerve Diseases | 1 | 1992 | 41 | 0.100 |
Why?
| | Opportunistic Infections | 1 | 1992 | 47 | 0.100 |
Why?
| | Hospitals, Military | 3 | 2007 | 26 | 0.100 |
Why?
| | Doxycycline | 1 | 2012 | 55 | 0.100 |
Why?
| | Child Abuse | 3 | 2013 | 516 | 0.100 |
Why?
| | Craniocerebral Trauma | 3 | 2013 | 154 | 0.100 |
Why?
| | Glucocorticoids | 4 | 2017 | 575 | 0.100 |
Why?
| | Follow-Up Studies | 8 | 2011 | 4898 | 0.100 |
Why?
| | Paralysis | 1 | 1992 | 72 | 0.100 |
Why?
| | Ketamine | 1 | 2012 | 84 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2011 | 1860 | 0.090 |
Why?
| | Foreign Bodies | 1 | 2013 | 103 | 0.090 |
Why?
| | Vision, Binocular | 4 | 2005 | 17 | 0.090 |
Why?
| | Middle Aged | 13 | 2016 | 30893 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2003 | 231 | 0.090 |
Why?
| | Anisometropia | 1 | 2011 | 1 | 0.090 |
Why?
| | Hyperopia | 1 | 2011 | 3 | 0.090 |
Why?
| | Orbital Cellulitis | 1 | 2011 | 15 | 0.090 |
Why?
| | Aged | 13 | 2016 | 21971 | 0.090 |
Why?
| | Silymarin | 1 | 2012 | 198 | 0.090 |
Why?
| | Facial Pain | 1 | 1990 | 12 | 0.090 |
Why?
| | Gingivitis | 1 | 1990 | 12 | 0.090 |
Why?
| | Retina | 3 | 2021 | 280 | 0.090 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 1667 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2013 | 260 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 336 | 0.080 |
Why?
| | Malpractice | 1 | 2010 | 38 | 0.080 |
Why?
| | Corneal Keratocytes | 2 | 2021 | 8 | 0.080 |
Why?
| | Light | 1 | 2013 | 355 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 1990 | 29 | 0.080 |
Why?
| | Immunoglobulin Light Chains | 1 | 1990 | 40 | 0.080 |
Why?
| | Fluorescein Angiography | 4 | 1999 | 141 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 80 | 0.080 |
Why?
| | Retinal Vessels | 1 | 1990 | 63 | 0.080 |
Why?
| | Aerospace Medicine | 3 | 2014 | 23 | 0.080 |
Why?
| | Drug Industry | 1 | 1990 | 106 | 0.080 |
Why?
| | Anti-Infective Agents | 2 | 2002 | 225 | 0.080 |
Why?
| | Nocardia Infections | 1 | 1989 | 8 | 0.080 |
Why?
| | Incidence | 4 | 2013 | 2619 | 0.080 |
Why?
| | Corneal Ulcer | 2 | 2004 | 15 | 0.080 |
Why?
| | Enteral Nutrition | 1 | 1990 | 184 | 0.070 |
Why?
| | Blood Vessels | 2 | 2021 | 184 | 0.070 |
Why?
| | Urinary Tract Infections | 2 | 1987 | 150 | 0.070 |
Why?
| | Color Perception Tests | 1 | 2007 | 3 | 0.070 |
Why?
| | Autopsy | 1 | 2007 | 92 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 686 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 389 | 0.070 |
Why?
| | Sudden Infant Death | 1 | 2007 | 27 | 0.070 |
Why?
| | Eye Movements | 3 | 2005 | 58 | 0.070 |
Why?
| | Prevalence | 2 | 2013 | 2549 | 0.070 |
Why?
| | Fundus Oculi | 6 | 1994 | 61 | 0.070 |
Why?
| | Accidents, Traffic | 2 | 2013 | 187 | 0.070 |
Why?
| | Shaken Baby Syndrome | 1 | 2006 | 5 | 0.070 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2006 | 5 | 0.070 |
Why?
| | Chromosome Inversion | 1 | 1986 | 17 | 0.070 |
Why?
| | Nasolacrimal Duct | 1 | 2006 | 7 | 0.070 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1986 | 56 | 0.070 |
Why?
| | Videotape Recording | 1 | 1986 | 34 | 0.070 |
Why?
| | Time Factors | 4 | 2017 | 6503 | 0.070 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2017 | 67 | 0.070 |
Why?
| | Tomography, Optical Coherence | 1 | 2007 | 182 | 0.060 |
Why?
| | Lasers, Excimer | 1 | 2006 | 29 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2006 | 36 | 0.060 |
Why?
| | Optic Nerve Diseases | 1 | 2006 | 33 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 1985 | 27 | 0.060 |
Why?
| | Health Surveys | 2 | 2006 | 492 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 1986 | 147 | 0.060 |
Why?
| | Skin Diseases, Infectious | 1 | 1985 | 15 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1416 | 0.060 |
Why?
| | Cell Survival | 2 | 2021 | 1077 | 0.060 |
Why?
| | Colorado | 4 | 2017 | 4392 | 0.060 |
Why?
| | Quality Control | 1 | 2006 | 156 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1992 | 888 | 0.060 |
Why?
| | Smoking Prevention | 1 | 1986 | 162 | 0.060 |
Why?
| | Refractive Surgical Procedures | 1 | 2005 | 5 | 0.060 |
Why?
| | Reoperation | 3 | 1999 | 550 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 1010 | 0.060 |
Why?
| | Pyoderma | 1 | 1984 | 2 | 0.060 |
Why?
| | Ethics | 1 | 2004 | 6 | 0.060 |
Why?
| | Night Blindness | 1 | 2004 | 6 | 0.060 |
Why?
| | Myxoma | 1 | 1984 | 12 | 0.060 |
Why?
| | Intellectual Disability | 1 | 1986 | 152 | 0.060 |
Why?
| | Mitral Valve Stenosis | 1 | 1984 | 18 | 0.060 |
Why?
| | Xerophthalmia | 1 | 2004 | 7 | 0.060 |
Why?
| | Organizational Objectives | 1 | 2004 | 70 | 0.060 |
Why?
| | Heart Neoplasms | 1 | 1984 | 49 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 335 | 0.060 |
Why?
| | Chloramphenicol | 1 | 1983 | 9 | 0.060 |
Why?
| | Ampicillin | 1 | 1983 | 14 | 0.060 |
Why?
| | Esophageal Diseases | 1 | 1984 | 27 | 0.050 |
Why?
| | Theophylline | 1 | 1984 | 64 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2005 | 289 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 469 | 0.050 |
Why?
| | Cross Infection | 1 | 1985 | 196 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 1986 | 230 | 0.050 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2003 | 26 | 0.050 |
Why?
| | Syndrome | 3 | 2020 | 335 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1669 | 0.050 |
Why?
| | Drug Packaging | 1 | 2003 | 41 | 0.050 |
Why?
| | Corneal Opacity | 2 | 2016 | 6 | 0.050 |
Why?
| | Pleura | 1 | 1983 | 21 | 0.050 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 1983 | 11 | 0.050 |
Why?
| | Femoral Fractures | 2 | 1992 | 74 | 0.050 |
Why?
| | Illinois | 2 | 2000 | 39 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2010 | 1266 | 0.050 |
Why?
| | Cholestasis | 1 | 1985 | 230 | 0.050 |
Why?
| | Counseling | 1 | 1986 | 386 | 0.050 |
Why?
| | Drug Combinations | 2 | 1997 | 323 | 0.050 |
Why?
| | Methylprednisolone | 1 | 2003 | 82 | 0.050 |
Why?
| | Citrobacter | 1 | 1982 | 1 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 1983 | 75 | 0.050 |
Why?
| | Cohort Studies | 3 | 2017 | 5369 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2005 | 330 | 0.050 |
Why?
| | Abducens Nerve Injury | 1 | 2002 | 1 | 0.050 |
Why?
| | Oculomotor Nerve Injuries | 1 | 2002 | 1 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 12320 | 0.050 |
Why?
| | Enterobacteriaceae Infections | 1 | 1982 | 36 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 1983 | 163 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 1981 | 17 | 0.050 |
Why?
| | Electroretinography | 1 | 2021 | 45 | 0.050 |
Why?
| | Hydrocephalus | 1 | 1982 | 107 | 0.040 |
Why?
| | Tibial Fractures | 1 | 1982 | 73 | 0.040 |
Why?
| | Parents | 2 | 2006 | 1306 | 0.040 |
Why?
| | Infant, Premature | 2 | 2017 | 536 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2003 | 734 | 0.040 |
Why?
| | Medical Records | 1 | 2001 | 169 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 530 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2736 | 0.040 |
Why?
| | Appendicitis | 1 | 1982 | 132 | 0.040 |
Why?
| | Cataract | 1 | 2003 | 194 | 0.040 |
Why?
| | Steroids | 1 | 2001 | 148 | 0.040 |
Why?
| | Acute Disease | 2 | 2019 | 968 | 0.040 |
Why?
| | Administration, Oral | 2 | 2017 | 757 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 205 | 0.040 |
Why?
| | Colon | 1 | 1982 | 251 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2005 | 515 | 0.040 |
Why?
| | Risk | 3 | 1989 | 852 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 1999 | 75 | 0.040 |
Why?
| | Vitreous Hemorrhage | 1 | 1999 | 5 | 0.040 |
Why?
| | Chlorambucil | 1 | 1999 | 9 | 0.040 |
Why?
| | Leukemia | 1 | 1981 | 229 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 4 | 1999 | 2521 | 0.040 |
Why?
| | Sodium Chloride | 1 | 1999 | 138 | 0.040 |
Why?
| | Physical Therapy Modalities | 1 | 1982 | 290 | 0.040 |
Why?
| | Lens, Crystalline | 1 | 1999 | 100 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 1999 | 159 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2017 | 14 | 0.040 |
Why?
| | Risk Assessment | 2 | 2017 | 3256 | 0.040 |
Why?
| | Prednisone | 1 | 1999 | 236 | 0.040 |
Why?
| | Blister | 1 | 2017 | 40 | 0.040 |
Why?
| | Brain | 1 | 2010 | 2618 | 0.040 |
Why?
| | Quality of Life | 2 | 2006 | 2680 | 0.040 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2017 | 81 | 0.040 |
Why?
| | Biological Availability | 1 | 2017 | 123 | 0.040 |
Why?
| | Bone Marrow | 1 | 1999 | 267 | 0.030 |
Why?
| | Optometry | 1 | 1997 | 6 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 173 | 0.030 |
Why?
| | Intraoperative Period | 1 | 1997 | 53 | 0.030 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 33 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 57 | 0.030 |
Why?
| | Body Weight | 1 | 2001 | 931 | 0.030 |
Why?
| | Administration, Topical | 1 | 1997 | 144 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 20 | 0.030 |
Why?
| | Battered Child Syndrome | 2 | 1992 | 6 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1490 | 0.030 |
Why?
| | Prognosis | 3 | 2020 | 3780 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 144 | 0.030 |
Why?
| | Rupture | 1 | 2016 | 100 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 167 | 0.030 |
Why?
| | Apoptosis | 2 | 2016 | 2437 | 0.030 |
Why?
| | Eye | 1 | 2016 | 103 | 0.030 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1995 | 7 | 0.030 |
Why?
| | Sarcoidosis | 1 | 2017 | 154 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1994 | 22 | 0.030 |
Why?
| | Pilot Projects | 1 | 2000 | 1558 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 1994 | 12 | 0.030 |
Why?
| | Scotoma | 1 | 1994 | 5 | 0.030 |
Why?
| | Choroid Diseases | 1 | 1994 | 10 | 0.030 |
Why?
| | Choroiditis | 1 | 1994 | 6 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 224 | 0.030 |
Why?
| | Accidents, Home | 1 | 2013 | 29 | 0.030 |
Why?
| | Ophthalmoplegia | 1 | 1993 | 8 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 1994 | 33 | 0.030 |
Why?
| | Facial Paralysis | 1 | 1993 | 17 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1152 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1993 | 43 | 0.030 |
Why?
| | Contraindications | 1 | 1993 | 88 | 0.030 |
Why?
| | Tamoxifen | 1 | 1994 | 200 | 0.030 |
Why?
| | Iris | 1 | 1993 | 19 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1168 | 0.030 |
Why?
| | Dark Adaptation | 1 | 2013 | 14 | 0.030 |
Why?
| | Aviation | 1 | 2013 | 8 | 0.030 |
Why?
| | Fungemia | 1 | 1992 | 4 | 0.030 |
Why?
| | Cranial Fossa, Posterior | 1 | 1992 | 16 | 0.030 |
Why?
| | Ocular Physiological Phenomena | 1 | 1992 | 9 | 0.030 |
Why?
| | Aspergillosis | 1 | 1992 | 21 | 0.030 |
Why?
| | Eye Diseases | 1 | 1993 | 78 | 0.020 |
Why?
| | Candidiasis | 1 | 1992 | 53 | 0.020 |
Why?
| | Irritants | 1 | 2012 | 43 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 625 | 0.020 |
Why?
| | Vision Disorders | 1 | 1993 | 135 | 0.020 |
Why?
| | Emergencies | 2 | 2009 | 162 | 0.020 |
Why?
| | Mycoses | 1 | 1992 | 70 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2018 | 548 | 0.020 |
Why?
| | Vision Disparity | 1 | 1991 | 3 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 240 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1943 | 0.020 |
Why?
| | Radiography | 3 | 1985 | 864 | 0.020 |
Why?
| | Thrombocytopenia | 1 | 2013 | 182 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2005 | 7040 | 0.020 |
Why?
| | Sex Factors | 3 | 1987 | 1949 | 0.020 |
Why?
| | Crohn Disease | 1 | 1994 | 211 | 0.020 |
Why?
| | Coloboma | 1 | 1990 | 4 | 0.020 |
Why?
| | Retinal Perforations | 1 | 1990 | 14 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1043 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 1990 | 34 | 0.020 |
Why?
| | Safflower Oil | 1 | 1990 | 5 | 0.020 |
Why?
| | Light Coagulation | 1 | 1990 | 8 | 0.020 |
Why?
| | Soybean Oil | 1 | 1990 | 14 | 0.020 |
Why?
| | Emulsions | 1 | 1990 | 43 | 0.020 |
Why?
| | Lung | 1 | 1983 | 3741 | 0.020 |
Why?
| | Sacroiliac Joint | 2 | 1994 | 35 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 1993 | 405 | 0.020 |
Why?
| | HEPES | 1 | 1989 | 2 | 0.020 |
Why?
| | Chondroitin | 1 | 1989 | 5 | 0.020 |
Why?
| | Tissue Preservation | 1 | 1989 | 11 | 0.020 |
Why?
| | Propionibacterium acnes | 1 | 1989 | 9 | 0.020 |
Why?
| | Chondroitin Sulfates | 1 | 1989 | 34 | 0.020 |
Why?
| | Nocardia asteroides | 1 | 1989 | 1 | 0.020 |
Why?
| | Sulfacetamide | 1 | 1989 | 1 | 0.020 |
Why?
| | Trimethoprim | 1 | 1989 | 7 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 1989 | 7 | 0.020 |
Why?
| | Gentamicins | 1 | 1989 | 52 | 0.020 |
Why?
| | Graft Rejection | 1 | 1992 | 557 | 0.020 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1989 | 39 | 0.020 |
Why?
| | Indians, North American | 1 | 1995 | 600 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 543 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 613 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1693 | 0.020 |
Why?
| | Phospholipids | 1 | 1990 | 209 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2335 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1990 | 197 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2007 | 18 | 0.020 |
Why?
| | Brain Injuries | 1 | 1992 | 468 | 0.020 |
Why?
| | Recurrence | 1 | 1990 | 1001 | 0.020 |
Why?
| | Piperazines | 1 | 1989 | 334 | 0.020 |
Why?
| | Orbit Evisceration | 1 | 2006 | 1 | 0.020 |
Why?
| | Forensic Pathology | 1 | 2006 | 7 | 0.020 |
Why?
| | Dacryocystorhinostomy | 1 | 2006 | 9 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2006 | 55 | 0.020 |
Why?
| | Hawaii | 1 | 1986 | 41 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1986 | 172 | 0.020 |
Why?
| | Chromosome Disorders | 1 | 1986 | 39 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3692 | 0.020 |
Why?
| | Klebsiella pneumoniae | 1 | 1985 | 41 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2009 | 283 | 0.020 |
Why?
| | Informed Consent | 1 | 1986 | 174 | 0.010 |
Why?
| | Tablets | 1 | 1984 | 37 | 0.010 |
Why?
| | Hirschsprung Disease | 1 | 1985 | 101 | 0.010 |
Why?
| | Abdominal Muscles | 1 | 1983 | 4 | 0.010 |
Why?
| | Mitral Valve | 1 | 1984 | 85 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 1983 | 8 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1985 | 59 | 0.010 |
Why?
| | Ulcer | 1 | 1984 | 29 | 0.010 |
Why?
| | Meningitis, Haemophilus | 1 | 1983 | 6 | 0.010 |
Why?
| | Hernia, Umbilical | 1 | 1983 | 16 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1992 | 1108 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1121 | 0.010 |
Why?
| | Haemophilus influenzae | 1 | 1983 | 62 | 0.010 |
Why?
| | Feces | 1 | 1985 | 432 | 0.010 |
Why?
| | Health Services Misuse | 1 | 1983 | 36 | 0.010 |
Why?
| | Angiostrongylus | 1 | 1982 | 1 | 0.010 |
Why?
| | Nematode Infections | 1 | 1982 | 4 | 0.010 |
Why?
| | Age Distribution | 1 | 2003 | 376 | 0.010 |
Why?
| | Infant, Premature, Diseases | 1 | 1983 | 95 | 0.010 |
Why?
| | Kidney | 1 | 1990 | 1305 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 1982 | 20 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1271 | 0.010 |
Why?
| | Attitude of Health Personnel | 2 | 1987 | 1090 | 0.010 |
Why?
| | Contracture | 1 | 1982 | 24 | 0.010 |
Why?
| | Leukemia, Lymphoid | 1 | 1981 | 27 | 0.010 |
Why?
| | Enema | 1 | 1982 | 44 | 0.010 |
Why?
| | Age Factors | 1 | 1989 | 3117 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 65 | 0.010 |
Why?
| | Glucagon | 1 | 1982 | 105 | 0.010 |
Why?
| | Regression Analysis | 1 | 2003 | 983 | 0.010 |
Why?
| | Skin | 1 | 1985 | 717 | 0.010 |
Why?
| | Hip Joint | 1 | 1982 | 157 | 0.010 |
Why?
| | Contrast Media | 1 | 1982 | 384 | 0.010 |
Why?
| | Knee Joint | 1 | 1982 | 366 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 5040 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1981 | 591 | 0.010 |
Why?
| | Spasm | 1 | 1994 | 19 | 0.010 |
Why?
| | Spondylitis | 1 | 1994 | 2 | 0.010 |
Why?
| | Tenosynovitis | 1 | 1994 | 12 | 0.010 |
Why?
| | Sulfasalazine | 1 | 1994 | 23 | 0.010 |
Why?
| | Crystallization | 1 | 1994 | 137 | 0.010 |
Why?
| | Middle East | 1 | 1993 | 11 | 0.010 |
Why?
| | Accommodation, Ocular | 1 | 1993 | 10 | 0.010 |
Why?
| | Cadaver | 1 | 1994 | 330 | 0.010 |
Why?
| | Rib Fractures | 1 | 1992 | 32 | 0.010 |
Why?
| | Posture | 1 | 1993 | 174 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 323 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 343 | 0.010 |
Why?
| | Reference Values | 1 | 1992 | 780 | 0.010 |
Why?
| | Postoperative Care | 1 | 1991 | 243 | 0.010 |
Why?
| | Drug Contamination | 1 | 1989 | 54 | 0.000 |
Why?
| | Culture Media | 1 | 1989 | 167 | 0.000 |
Why?
| | Macular Degeneration | 1 | 1990 | 157 | 0.000 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1985 | 4 | 0.000 |
Why?
| | Suppuration | 1 | 1985 | 9 | 0.000 |
Why?
| | Gallium Radioisotopes | 1 | 1985 | 14 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1985 | 123 | 0.000 |
Why?
| | Breast Neoplasms | 1 | 1994 | 2139 | 0.000 |
Why?
| | Aging | 1 | 1990 | 1770 | 0.000 |
Why?
| | Pediatrics | 1 | 1987 | 1061 | 0.000 |
Why?
|
|
Enzenauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|